No Data
No Data
Earnings Call Summary | STAGEZERO LIFE SCIENCES LTD(SZLSF.US) Q1 2024 Earnings Conference
The following is a summary of the StageZero Life Sciences Ltd. (SZLSF) Q1 2024 Earnings Call Transcript:Financial Performance:StageZero reported a decline in Q1 2024 revenue due to staff illnesses lea
Stagezero Life Sciences GAAP EPS of $0.00
StageZero Life Sciences, Ltd Announces Q1 2024 Financial Results and Operational Update
TORONTO, ON / ACCESSWIRE / May 17, 2024 / StageZero Life Sciences ("StageZero" or the "Company") (TSX:SZLS), an integrated healthcare company with the first and only mRNA multi-cancer diagnostic for s
StageZero Life Sciences Provides an Update on Application for Management Cease Trade Order
TORONTO, ON / ACCESSWIRE / April 5, 2024 / StageZero Life Sciences, Ltd. (TSX:SZLS)(OTCQB:SZLSF) ("StageZero" or the "Company"), an integrated healthcare company with the first and only mRNA multi-can
StageZero Life Sciences Announces Delay to Fourth Quarter and Year End 2023 Financial Results
TORONTO, ON / ACCESSWIRE / April 2, 2024 / StageZero Life Sciences, Ltd. (TSX:SZLS)(OTCQB:SZLSF) ("StageZero" or the "Company"), an integrated healthcare company with the first and only mRNA multi-can
Stagezero Life Sciences GAAP EPS of -$0.01, Revenue of $0.75M
No Data